1 completed, 1 recruiting, 1 terminated. 1 Early Phase 1, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Lincomycin: new trials by email Literature Review of Lincomycin trials Research Report on Lincomycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Staphylococcus Aureus Network Adaptive Platform Trial Cefazolin, Penicillin, Clindamycin - Staphylococcus Aureus Bacteremia | Phase 4 | Recruiting | University of Melbourne | 8000 | 2022-02-16 | 2026-05-06 |
| Patients Response to Early Switch To Oral:Osteomyelitis Study oral antibiotics, intravenous antibiotics - Osteomyelitis | Early Phase 1 | Terminated | Julio Ramirez | 11 | 2014-03-06 | 2021-04-06 |
| Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule Lincomycin - Bacterial Infections | Phase 1 | Completed | Pfizer | 36 | 2009-04-01 | 2011-04-26 |
Bacterial Infections (1) · Osteomyelitis (1) · Staphylococcal Infections (1)
Julio Ramirez (1) · Pfizer (1) · University of Melbourne (1)
United States (2) · Australia (1) · Brazil (1) · Canada (1) · France (1) · Germany (1) · Israel (1) · Japan (1) · Netherlands (1) · New Zealand (1) · Singapore (1) · South Africa (1) · Sweden (1) · United Kingdom (1)
David Seligson, MD (1) · Julio Ramirez, MD (1) · Prof Joshua Davies (1) · Prof Steven Tong (1)
PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 39934879, PMID 41433510, PMID 42308484, PMID 42309115, PMID 4902833, PMID 8948280